Search

Search Results

• A Phase II international, multicenter study of oral panobinostat (LBH589) in patients with refractory cutaneous T-cell lymphoma

  MG Bernengo, F Vanaclocha, M Duvic, T Kuzel, F Kerdel, L Pinter-Brown, A Bosly, C Okada, D Breneman, PL Zinzani, J Becker, L Hughey, M Ardaiz, J Zain, L Zhang

  2009-06-23

  Published: June 23, 2009

  183

  PDF: 192

• Phase II trial of romidepsin (FK228 or depsipeptide) in peripheral T-cell lymphoma: clinical activity and molecular markers

  RL Piekarz, R Frye, M Turner, J Turner, S Allen, MH Kirschbaum, J Zain, M Prince

  2009-06-10

  Published: June 10, 2009

  209

  PDF: 296